4173Frequency-domain optical coherence tomography in the evaluation of the left main coronary artery stenosis. Correlation with fractional flow reresve
Bouki, K P, Sakkali, E, Vlad, D, Karakidis, S, Asariotis, K, Kirimis, K, Kotsakis, A, Iliopoulos, D, Toutouzas, K
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
P5512Can we use frequency domain optical coherence tomography to evaluate left main coronary artery disease?
Bouki, K P, Sakkali, E, Stergiouli, I, Goulas, N, Asariotis, K, Kirimis, K, Kotsakis, A, Iliopoulos, D, Toutouzas, K
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
UCLA l-08: A phase ib/II study of combined HER inhibition adding necitumumab and trastuzumab to osimertinib in patients with refractory EGFR-mutated lung cancer
Goldman, Jonathan W., Cummings, Amy Lauren, Arzoo, Karo K., Hu, Eddie Hong-Lung, Garon, Edward B., Kirimis, Evangelia K., Olevsky, Olga, DiCarlo, Brian Anthony, Davidson, Sheldon J., Kaul, Anita, Noor, Zorawar Singh, Mendenhall, Melody A., Wong, Deborah J.L., Huang, Holly K.T., Velez, Maria A, Chauv, James, Yarden, Yosef, Slamon, Dennis J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer
Hurvitz, Sara A., Wang, Lisa S., Chan, David, Phan, Vu, Lomis, Thomas, McAndrew, Nicholas Patrick, Spring, Laura, Tetef, Merry L., Villa, Deborah, Applebaum, Steven, Chamberlain, Erin, Dakhil, Shaker R., DiCarlo, Brian Anthony, Kim, David D., Kirimis, Evangelia K., Lawler, William E., Master, Aashini K., Kivork, Christine, Chauv, James, Bardia, Aditya
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article